Merbromin or mercurochrome

This classification denotes an anti-infective agent with the molecular formula C20H7Br2HgO5.2Na.HO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M0T18YH28D, chemically known as 2,7-dibromo-4-hydroxymercurifluoresceine disodium salt but generally known as merbromin, which bears US NIH Compound Identifier 8505. European Medicines Agency schedules Merbromin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08769MIG. The term MERBROMIN is an International Non-Proprietary Name. World Health Organization schedules merbromin in its Anatomical Therapeutic Chemical (ATC) Classification. MERBROMIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule merbromin under HS 29329985 and SITC 51569. As of Q4 2014, MERBROMIN remains the US FDA Preferred Term for this commodity. Merbromin bears US NLM identifiers UMLS ID C0025397 and NCI Concept Code C82319. SMILES: [HG]([OH2])C1C2OC3C(C4(OC(=O)C5C4CCCC5)C2CC(BR)C1O)CC(BR)C(O)C3.[NA].[NA].